風華高科(000636.SZ):目前阻容感新增產能均有釋放並批量供貨客户
格隆匯7月17日丨風華高科(000636.SZ)近日在接待機構投資者調研時表示,近年來公司重點圍繞阻容感三大產品規劃新產能,投資建設“祥和工業園高端電容基地項目”、“新增月產280億隻片式電阻器技改擴產項目”、“新增月產1億隻一體成型電感技改擴產項目”和“新增月產40億隻疊層電感器技改擴產項目”,並結合公司戰略規劃和市場需求情況推進產能建設。目前阻容感新增產能均有釋放並批量供貨客户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.